Trial site
Ambenet GmbH Das Ambulante Behandlungsnetz
- 13running trials
- 10closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Obesity14 trials
- Type 2 diabetes5 trials
- Migraine4 trials
- Osteoarthritis3 trials
- Type 1 diabetes3 trials
- Cytomegalovirus infection1 trial
- Depression1 trial
- Irritable bowel syndrome1 trial
- Phase
- Phase 321 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed10 trials
- Recruiting7 trials
- Active, not recruiting6 trials
- Lead sponsor
- Eli Lilly and Company7 trials
- AbbVie4 trials
- Novo Nordisk A/S3 trials
- Amgen Inc.1 trial
- Ascletis Pharma (China) Co. Ltd.1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity6 recruiting
- Osteoarthritis2 recruiting
- Type 2 diabetes2 recruiting
- Irritable bowel syndrome1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
Completed
Completed
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Terminated
Completed
Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026